SAB Biotherapeutics (SABS) Cash & Equivalents (2020 - 2026)
SAB Biotherapeutics (SABS) recorded Cash & Equivalents of $8.27 million in Q2 2026, up 123.9% from $3.69 million a year earlier but down 59.7% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, SAB Biotherapeutics reported Cash & Equivalents of $10.5 million, up 18.0% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -3.6% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $8.9 million in FY2024 (-84.3%), $56.57 million in FY2023 (+275.9%), $15.05 million in FY2022 (-54.7%) and $33.21 million in FY2021 (+163.3%).
- Quarterly Cash & Equivalents has ranged from $2.43 million in Q3 2023 to $56.57 million in Q4 2023 over the past five years.
- On a year-over-year basis, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 85.3% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 279.3% in Q3 2024, against a decline of 84.3% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $20.52 million (Q1 2026), $10.5 million (Q4 2025) and $29.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | SAB Biotherapeutics | 255.49 Mn | 255.49 Mn | - | 8.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.27 Mn |
| Mar 31, 2026 | 20.52 Mn |
| Dec 31, 2025 | 10.50 Mn |
| Sep 30, 2025 | 29.42 Mn |
| Jun 30, 2025 | 3.69 Mn |
| Mar 31, 2025 | 5.64 Mn |
| Dec 31, 2024 | 8.90 Mn |
| Sep 30, 2024 | 9.20 Mn |
| Jun 30, 2024 | 17.24 Mn |
| Mar 31, 2024 | 14.03 Mn |
| Dec 31, 2023 | 56.57 Mn |
| Sep 30, 2023 | 2.43 Mn |
| Jun 30, 2023 | 7.77 Mn |
| Mar 31, 2023 | 13.06 Mn |
| Dec 31, 2022 | 15.05 Mn |
| Sep 30, 2022 | 8.33 Mn |
| Jun 30, 2022 | 16.62 Mn |
| Mar 31, 2022 | 22.41 Mn |
| Dec 31, 2021 | 33.21 Mn |
| Sep 30, 2021 | 10.75 Mn |
API Access
SAB Biotherapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();